CIBC World Market
NYMX

CIBC World Market’s Nymox Pharmaceutical Corp NYMX Stock Holding History

CIBC World Market’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-31,372
Closed -$190K – 740
2013
Q4 		$190K Sell
31,372
-18,942
-38% -$129K ﹤0.01% 641
2013
Q3 		$333K Buy
50,314
+1,786
+4% +$11.7K ﹤0.01% 514
2013
Q2 		$246K Buy
+48,528
New +$246K ﹤0.01% 516

Other funds holding NYMX

Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
WP
WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MCM
Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
EVC
Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GG
Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return

CIBC World Market's NYMX Position: Q1 2014 in Review

CIBC World Market sold out of Nymox Pharmaceutical Corp (NYMX) in Q1 2014, closing a stake of 31,372 shares — an estimated $190K sold.

CIBC World Market first reported a position in NYMX in Q2 2013 and held it in 3 quarters. The position peaked at $333K in Q3 2013. 32 funds tracked by Wall St. Rank hold NYMX as of Q1 2014.

  • CIBC World Market reported no remaining Nymox Pharmaceutical Corp position as of Q1 2014 after selling out during the quarter.
  • CIBC World Market sold 31,372 Nymox Pharmaceutical Corp shares in Q1 2014, an estimated $190K.
  • CIBC World Market first reported a position in Nymox Pharmaceutical Corp in Q2 2013 and held it in 3 quarters.
  • CIBC World Market's Nymox Pharmaceutical Corp position peaked at $333K in Q3 2013.
  • 32 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q1 2014.

Based on CIBC World Market's 13F filing for Q1 2014, filed 13 May 2014.